Kansas City, KS – What if clinical trials could help prevent cancer before it ever develops? While most people associate clinical trials with treating patients who already have cancer, researchers are exploring ways to reduce cancer risk in otherwise healthy people. Wednesday on Open Mics with Dr. Stites, Dr. Lauren Nye of The University of Kansas Cancer Center explains how cancer prevention trials work, who may qualify and how new research could change the future of cancer prevention.
Dr. Lauren Nye, Clinical Director, High-Risk Breast Clinic, The University of Kansas Cancer Center
Dr. Nye discusses how cancer prevention clinical trials differ from traditional cancer treatment trials, including why healthy individuals may be eligible to participate.
She explains what puts someone at high risk for cancer beyond inherited genetic factors.
Shares how her National Cancer Institute R50 Clinical Scientist Award supports research to modernize breast cancer prevention and address barriers to participation among people who may not know they're at increased risk.
She explains how researchers are studying medications, vaccines, lifestyle changes and screening approaches to help reduce cancer risk.
She discusses cancer prevention research beyond breast cancer and the types of trials currently being studied.
Dr. Nye explains how people can learn whether they qualify for a prevention trial, what participation involves and how to get started.
